Is there a role for prophylaxis against atrial fibrillation for patients undergoing lung surgery? | Zendy

Vivek Shrivastava | Zendy; Brian Nyawo | Zendy; Joel Dunning | Zendy; G N Morritt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is there a role for prophylaxis against atrial fibrillation for patients undergoing lung surgery?

Author(s) -

Vivek Shrivastava,

Brian Nyawo,

Joel Dunning,

G N Morritt

Publication year - 2004

Publication title -

interactive cardiovascular and thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 56

eISSN - 1569-9293

pISSN - 1569-9285

DOI - 10.1016/j.icvts.2004.08.002

Subject(s) - medicine , atrial fibrillation , randomized controlled trial , diltiazem , cardiothoracic surgery , clinical trial , cardiac surgery , surgery , intensive care medicine , anesthesia , cardiology , calcium

A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed whether prophylactic anti-arrhythmic drugs may prevent atrial fibrillation (AF) following lung resection. Altogether 457 papers were found using the reported search, of which 14 presented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. We identified single randomized trials that have demonstrated a benefit for Diltiazem, Bupivacaine epidural and magnesium for prophylaxis against AF in patients undergoing non-cardiac thoracic surgery, with a number needed to treat of between 4 and 8 with these regimes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research